Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction
Introduction
Acute hyperglycemia and contrast-induced nephropathy (CIN) are frequently observed in non-ST elevation myocardial infarction (NSTEMI) patients undergoing percutaneous coronary intervention (PCI), and both are associated with an increased mortality rate. We investigated the possible association between acute hyperglycemia and CIN in patients with NSTEMI undergoing PCI.
Materials and methods
We retrospectively enrolled 281(149, 53% men) NSTEMI patients undergoing PCI. For each patient, plasma glucose levels were secreened at hospital admission. Acute hyperglycemia was defined as glucose levels> 198 mg/dl. CIN was defined as an increase in serum creatinine 25% or 0.5 mg/dl from baseline in the first 48–72 hours.
Results
Overall, 44 (15.7%) patients had acute hyperglycemia. Patients with acute hyperglycemia had higher incidence of CIN than those without acute hyperglycemia (29.5 vs 5.1%, P
Source: Cardiovascular Endocrinology - Category: Cardiology Tags: Original Articles Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Endocrinology | Heart | Heart Attack | Hospitals | Percutaneous Coronary Intervention